BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22138849)

  • 21. Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.
    Cooper MR; Durand CR; Beaulac MT; Steinberg M
    Ann Pharmacother; 2011 Sep; 45(9):1094-102. PubMed ID: 21862714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
    Bliziotis IA; Michalopoulos A; Kasiakou SK; Samonis G; Christodoulou C; Chrysanthopoulou S; Falagas ME
    Mayo Clin Proc; 2005 Sep; 80(9):1146-56. PubMed ID: 16178494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Penicillin and aminoglycoside in febrile neutropenia].
    Torfoss D; Høiby EA; Holte H; Kvaløy S
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2738-40. PubMed ID: 19079423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia.
    Nakagawa Y; Suzuki K; Ohta K; Hino M; Ohyashiki K; Kanamaru A; Tamura K; Urabe A; Masaoka T;
    J Infect Chemother; 2013 Feb; 19(1):103-11. PubMed ID: 22948387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial empirical antimicrobial therapy: duration and subsequent modifications.
    Tamura K
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S59-64. PubMed ID: 15250024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis.
    Furno P; Bucaneve G; Del Favero A
    Lancet Infect Dis; 2002 Apr; 2(4):231-42. PubMed ID: 11937423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
    Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
    Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbapenem Antibiotics for the Empiric Treatment of Nosocomial Pneumonia: A Systematic Review and Meta-analysis.
    Howatt M; Klompas M; Kalil AC; Metersky ML; Muscedere J
    Chest; 2021 Mar; 159(3):1041-1054. PubMed ID: 33393468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
    Chuang YY; Hung IJ; Yang CP; Jaing TH; Lin TY; Huang YC
    Pediatr Infect Dis J; 2002 Mar; 21(3):203-9. PubMed ID: 12005083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefepime monotherapy for treatment of febrile neutropenia in children.
    Ariffin H; Ai CL; Lee CL; Abdullah WA
    J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbapenems versus other beta-lactams in treating severe infections in intensive care: a systematic review of randomised controlled trials.
    Edwards SJ; Clarke MJ; Wordsworth S; Emmas CE
    Eur J Clin Microbiol Infect Dis; 2008 Jul; 27(7):531-43. PubMed ID: 18373108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease.
    Petrilli AS; Melaragno R; Barros KV; Silva AA; Kusano E; Ribeiro RC; Bianchi A
    Pediatr Infect Dis J; 1993 Nov; 12(11):916-21. PubMed ID: 8265281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
    Ford CD; Coombs J; Stofer MG; Lopansri BK; Webb BJ; Ostronoff F; Asch J; Hoda D
    Infect Control Hosp Epidemiol; 2019 Jul; 40(7):774-779. PubMed ID: 31046849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of febrile neutropenia with cefepime monotherapy.
    Jándula BM; Martino R; Gurgi M; Manteiga R; Sierra J
    Chemotherapy; 2001; 47(3):226-31. PubMed ID: 11306793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis.
    Teuffel O; Ethier MC; Alibhai SMH; Beyene J; Sung L
    Ann Oncol; 2011 Nov; 22(11):2358-2365. PubMed ID: 21363878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of the clinical outcome of carbapenem monotherapy in the adjunctive treatment of intra-abdominal infections.
    Chang DC; Wilson SE
    Am J Surg; 1997 Sep; 174(3):284-90. PubMed ID: 9324138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic regimens for postpartum endometritis.
    Mackeen AD; Packard RE; Ota E; Speer L
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001067. PubMed ID: 25922861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Febrile neutropenia in children with cancer.
    Paulus S; Dobson S
    Adv Exp Med Biol; 2009; 634():185-204. PubMed ID: 19280859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation].
    Zikesoá E; Hnátková M; Vacková B; Jedlicková A; Klener P; Trnený M
    Cas Lek Cesk; 2006; 145(5):383-6, 388-9. PubMed ID: 16755776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.